FIELD: medicine.
SUBSTANCE: invention relates to extreme medicine, catastrophe medicine, neurology and psychiatry. Invention proposes a new antidepressant: N-carbamoylmethyl-4-phenyl-2-pyrrolidone (trade names: phenotropil, carfedon) known early as the preparation exhibiting hypotensive, anti-ischemic, nootropic and anticonvulsant effects. New agent exhibits the absence of sedative and cholinolytic effect and absence for addiction to it and withdrawal syndrome also.
EFFECT: valuable properties of agent, expanded assortment of agents of indicated designation.
5 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIDEPRESSANT FOR CORRECTION OF SIDE EFFECTS FROM NEUROLEPTICS | 2019 |
|
RU2746012C2 |
| COMBINED COMPOSITION OF SUBSTANCES WITH COMPLEX PHARMACOLOGICAL ACTIVITY | 2014 |
|
RU2622991C2 |
| 9-[2-(4-ISOPROPYLPHENOXY)ETHYL]ADENINE POSSESSING ANTIDEPRESSANT AND STRESS-RELIEVING ACTION | 2013 |
|
RU2529817C1 |
| ANTIDEPRESSANT DRUG AND METHOD FOR PREPARING IT | 2013 |
|
RU2519759C1 |
| SUBSTANCE OF NEUROTROPIC- NEUROREGULATING ACTIVITY | 2006 |
|
RU2329804C2 |
| LIGANDS OF TRANSLOCATOR PROTEIN TSPO, HAVING ANTIDEPRESSANT AND NOOTROPIC ACTIVITY | 2015 |
|
RU2699568C2 |
| ANTIDEPRESSANT | 2012 |
|
RU2535027C2 |
| ANTIDEPRESSANT, ANXIOLYTIC, NEUROPROTECTIVE AND IMMUNOSTIMULATING AGENT | 2010 |
|
RU2429834C1 |
| ANTIDEPRESSANT AGENT | 2018 |
|
RU2741938C2 |
| ANTIDEPRESSIVE AGENT | 2006 |
|
RU2363480C2 |
